| Document Type
|
:
|
BL
|
| Record Number
|
:
|
732376
|
| Doc. No
|
:
|
b552164
|
| Main Entry
|
:
|
Michael Sosin
|
| Title & Author
|
:
|
Heart Failure : : a Colour Handbook.\ Michael Sosin
|
| Edition Statement
|
:
|
7th ed
|
| Publication Statement
|
:
|
London, GBR: CRC Press, 2006
|
| Series Statement
|
:
|
Medical Color Handbook.
|
| Page. NO
|
:
|
(145 pages).
|
| ISBN
|
:
|
1840765232
|
|
|
:
|
: 9781840765236
|
| Notes
|
:
|
Malignant ventricular arrhythmias and sudden cardiac death.
|
| Contents
|
:
|
Abbreviations; Preface; Chapter 1 Epidemiology; What is heart failure?; Systolic heart failure; Diastolic heart failure; The scope of the problem; Incidence; Prevalence; Who is at risk?; Underlying aetiology; Risk of developing heart failure; Effect of ethnicity; Heart failure in the 'developing' world; Morbidity and quality of life; Prognosis; The economic burden of chronic heart failure; Summary; Further reading; Chapter 2 Clinical features; Introduction; Mode of presentation; Symptoms of heart failure; General; Breathlessness; Peripheral oedema; Signs of heart failure. Alterations in the extracellular matrixSummary; Further reading; Chapter 4 Investigations; Introduction; Electrocardiogram; Chest X-ray; Blood tests; Full blood count; Cardiac enzymes and cardiac troponins; Renal function; Liver function and thyroid function; Brain natriuretic peptide; Echocardiography; Nuclear scanning; Magnetic resonance imaging; Cardiac catheterization; Exercise testing; Heart rate variability; Further reading; Chapter 5 Drugs affecting the renin-angiotensin- aldosterone system and diuretics; Introduction; Angiotensin-converting enzyme inhibitors; Mechanism of action. Clinical benefitsAdministration of angiotensin-converting enzyme inhibitors; Ethnicity and ACE inhibition; Adverse effects; Aldosterone escape; Angiotensin II receptor blockers; Aldosterone antagonists; Diuretics; Loop diuretics; Thiazide diuretics; Potassium-sparing diuretics; Adverse effects; Diuretic resistance; Further reading; Chapter 6 Beta-blockers and inotropes; Beta-blockers; Mechanisms of action; Studies of beta-blockers in heart failure; Choice of beta-blocker; Administration; Positive inotropes; Digoxin; Sympathomimetics; Phosphodiesterase inhibitors; Summary; Further reading. Chapter 7 Other vasodilators: nitrates and calcium channel blockersClassification of vasodilators; Principles of vasodilator therapy in heart failure; Nitrates; Mechanism of action; Haemodynamic benefits; Nitrates and heart failure; Nitrate resistance and tolerance; Nicorandil; Calcium channel blockers; Classification and mechanism of action; Calcium channel blockers and heart failure; Summary; Further reading; Chapter 8 Antiarrhythmic and antithrombotic therapy in heart failure; Introduction; Antiarrhythmic drug therapy in heart failure; Atrial fibrillation.
|
| Subject
|
:
|
Heart failure -- Diagnosis.
|
| Subject
|
:
|
Heart failure -- Treatment.
|
| Added Entry
|
:
|
Gregory Y H Lip
|
|
|
:
|
Gurbir Bhatia
|
|
|
:
|
Michael K Davies
|
|
|
:
|
Michael Sosin
|